Lattice Capital Management, LLC Sorrento Therapeutics, Inc. Transaction History
Lattice Capital Management, LLC
- $109 Million
- Q3 2024
A detailed history of Lattice Capital Management, LLC transactions in Sorrento Therapeutics, Inc. stock. As of the latest transaction made, Lattice Capital Management, LLC holds 51,800 shares of SRNE stock, worth $17,094. This represents 0.02% of its overall portfolio holdings.
Number of Shares
51,800
Previous 51,800
-0.0%
Holding current value
$17,094
Previous $17,000
-0.0%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SRNE
# of Institutions
12Shares Held
5.47MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA5.22MShares$1.72 Million1.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2110KShares$36,3000.12% of portfolio
-
High Point Advisor Group LLC Downers Grove, IL22.3KShares$7,3420.0% of portfolio
-
Slate Stone Wealth, LLC21.4KShares$7,0720.0% of portfolio
-
Frontier Wealth Management LLC Kansas City, MO20.5KShares$6,7650.0% of portfolio
About Sorrento Therapeutics, Inc.
- Ticker SRNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 449,952,000
- Market Cap $148M
- Description
- Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...